Jie Zhang

Affiliations: 
Georgia State University, Atlanta, GA, United States 
Google:
"Jie Zhang"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shan Y, Si R, Wang J, et al. (2020) Discovery of novel anti-angiogenesis agents. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization. European Journal of Medicinal Chemistry. 205: 112654
Pan X, Liang L, Sun Y, et al. (2019) Discovery of novel Bcr-Abl inhibitors with flexible linker. Part 1: Confirmation optimization of phenyl-1H-indazol-3-amine as hinge binding moiety. European Journal of Medicinal Chemistry. 178: 232-242
Wang J, Chen Q, Shan Y, et al. (2019) Activity-based proteomic profiling: The application of photoaffinity probes in the target identification of bioactive molecules Trends in Analytical Chemistry. 115: 110-120
Shan Y, Si R, Wang J, et al. (2018) Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs. European Journal of Medicinal Chemistry. 164: 440-447
Pan X, Liang L, Si R, et al. (2018) Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol. European Journal of Medicinal Chemistry. 163: 1-9
Zhan Y, Zhang H, Dai B, et al. (2018) A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer. Oncology Reports
Shan Y, Wang B, Zhang J. (2018) New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs. Medicinal Research Reviews
Zhang L, Shan Y, Ji X, et al. (2017) Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget. 8: 104745-104760
Li C, Shan Y, Sun Y, et al. (2017) Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4. European Journal of Medicinal Chemistry
Sun Y, Shan Y, Li C, et al. (2017) Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors. European Journal of Medicinal Chemistry. 141: 373-385
See more...